Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |